Luspatercept as a therapy for myelodysplastic syndromes with ring sideroblasts.
Expert Rev Hematol
; 14(6): 509-516, 2021 06.
Article
in En
| MEDLINE
| ID: mdl-34161752
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Myelodysplastic Syndromes
Type of study:
Diagnostic_studies
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Aged
/
Humans
Language:
En
Journal:
Expert Rev Hematol
Journal subject:
HEMATOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Reino Unido